Abstract | OBJECTIVE: METHODS: The study was a prospective evaluation of patients undergoing twice-weekly treatments with either acupuncture alone (single-modality, group A) or with additional manual-movement and mind-body therapies (multimodality, group B), for 6 weeks. Symptom severity was assessed at baseline, 6 weeks, and 9 weeks using the Functional Assessment of Cancer Therapy- Taxane (FACT-Tax) tool; and von Frey perception thresholds. Additional symptoms were also assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the Measure Yourself Concerns and Wellbeing (MYCaW) study tool. RESULTS: For the 120 participants (60 in each study arm), baseline to 6-week scores were similar in both groups for improved FACT-Tax physical wellbeing and scores for hand numbness/tingling; EORTC physical functioning and global health status; and MYCaW scores. FACT-Tax taxane subscales and scores for foot numbness/tingling improved only in group A (p=0.038), while emotional wellbeing FACT-Tax (p=0.02) and EORTC pain (p=0.005) improved only in group B. Group B showed greater improvement for FACT-Tax neuropathy-related concerns than group A at 24 hours (p=0.043) and 7 days (p=0.009) after the first treatment. CONCLUSION: Acupuncture alone or with additional integrative oncology modalities may help reduce neuropathy-related symptoms. The single-modality group demonstrated greater improvement for foot numbness/tingling, and the multimodality group demonstrated improvement for pain and improved emotional wellbeing and neuropathy-related concerns in the first week of treatment. TRIAL REGISTRATION NUMBER: NCT03290976.
|
Authors | Eran Ben-Arye, Dorit Gamus, Noah Samuels, Elad Schiff, David Hausner, Orit Gressel, Samuel Attias, Ofer Lavie, Adi David, Katerina Shulman, Abed Agbarya |
Journal | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
(Int J Gynecol Cancer)
Vol. 33
Issue 5
Pg. 792-801
(05 01 2023)
ISSN: 1525-1438 [Electronic] England |
PMID | 36600535
(Publication Type: Randomized Controlled Trial, Multicenter Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. |
Chemical References |
|
Topics |
- Humans
- Integrative Oncology
- Quality of Life
(psychology)
- Hypesthesia
- Acupuncture Therapy
- Peripheral Nervous System Diseases
(chemically induced)
- Taxoids
(adverse effects)
- Pain
- Surveys and Questionnaires
|